Prospective trial compares treatments in matched DME eyes of poor anti-VEGF responders

FLORENCE, Italy — A small prospective trial comparing the effect of two drugs showed better results with a dexamethasone implant than monthly ranibizumab when the same patient with diabetic macular edema previously did not respond well to ranibizumab.Eleven patients were included. They were stable, chronic patients with well-controlled diabetes, equal diabetic retinopathy and macular edema in both eyes, and a symmetric history of consistent anti-VEGF treatment every 4 to 6 weeks with suboptimal success and persistent DME, Tarek Hassan, MD, said at the FLOREtina meeting.

Eye Implant for Producing Tears to Fight Dry Eye Syndrome

Dry eye syndrome may soon be treated with a new implant developed by a team led by researchers at Stanford University. The team identified the afferent neural pathway as being an excellent target for stimulation in order to activate tear production. They built a device that has platinum foil electrodes implanted under the inferior lacrimal […]

The post Eye Implant for Producing Tears to Fight Dry Eye Syndrome appeared first on Medgadget.